Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Avalon BioVentures is a San Diego-based biotech venture fund founded over 40 years ago. The firm focuses on investing in and building pioneering biotech companies that address critical unmet medical needs. Avalon BioVentures emphasizes a hands-on approach, working closely with entrepreneurs to provide capital, expertise, mentorship, and infrastructure necessary for translating scientific innovations into therapies.
Over the decades, Avalon has established a strong presence in the biotech venture capital space, with a commitment to supporting early-stage life sciences innovations. The firm has a long-standing history of successful investments, including notable exits such as the $2.5 billion sale of Synthorx, Inc. to Sanofi. Avalon BioVentures operates with a fully integrated operational model through its ABV Accelerator, which enhances the development capabilities of its portfolio companies.
Avalon BioVentures invests in early-stage life sciences innovations, particularly those that are first-in-class and address significant medical needs. The firm targets pre-seed, seed, and Series A stages, focusing on biotech and healthcare sectors. Their investment strategy is characterized by a willingness to take on scientific risks, seeking opportunities that are often too early for other investors.
The ABV Accelerator plays a crucial role in Avalon’s investment approach, providing portfolio companies with access to scientific, operational, and financial resources. This integrated support system is designed to expedite development timelines and optimize capital efficiency, ensuring that startups can effectively translate their scientific innovations into viable therapies.
Avalon BioVentures has a diverse portfolio of notable companies, including:
Jay B. Lichter, Ph.D. - Managing Partner. Jay has extensive experience in the biotech sector, having led numerous successful investments and exits. His expertise lies in identifying promising life sciences innovations and guiding them through the development process.
To pitch Avalon BioVentures, founders should visit their website at avalonbioventures.com. It is important to include a comprehensive pitch deck that outlines the scientific innovation, market opportunity, and team qualifications. Avalon prefers detailed presentations that highlight the potential impact of the innovation on healthcare.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
Avalon BioVentures runs the ABV Accelerator, which provides portfolio companies with essential resources for scientific, operational, and financial support. This program is designed to expedite development timelines and optimize capital efficiency for early-stage biotech companies. Startups interested in the accelerator can apply through the Avalon BioVentures website.
What are Avalon BioVentures' investment criteria?
Avalon BioVentures focuses on early-stage life sciences innovations that are first-in-class and address significant medical needs. They are willing to take on scientific risks and invest in opportunities that are often too early for other investors.
How can I pitch to Avalon BioVentures?
Founders can submit their pitches through the Avalon BioVentures website at avalonbioventures.com. It is recommended to include detailed information about the scientific innovation, market potential, and team background in the pitch deck.
What makes Avalon BioVentures different from other investors?
Avalon BioVentures emphasizes a hands-on approach, providing not only capital but also mentorship, expertise, and infrastructure to help startups succeed. Their ABV Accelerator offers integrated support to expedite development timelines.
What is the geographic focus of Avalon BioVentures?
The firm primarily invests in North America, targeting biotech and healthcare sectors.
What is the typical check size for investments?
Avalon BioVentures invests at the pre-seed, seed, and Series A stages, with check sizes varying based on the specific needs of the portfolio companies.
What kind of post-investment involvement does Avalon BioVentures have?
Avalon BioVentures maintains a hands-on approach post-investment, providing ongoing support through mentorship, operational guidance, and access to their network of resources.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.